My PCR
Create Account
Logo PCR

Imaging in Coronary Interventions

Coronary angiography has historically served as the gold standard for diagnosis of coronary artery disease and guidance of percutaneous coronary intervention (PCI), but the evolution of PCI would not have been possible without intravascular imaging which provides unique insights about coronary artery pathology.

Over the last 30 years IVUS and, more recently, optical coherence tomography (OCT) have been extensively used to examine the extent and severity of coronary artery disease (CAD), guide PCI in complex lesions, and assess the performance of emerging devices introduced to treat CAD. In this section, you will find a selection of resources showing the use of imaging in real-life scenarios.

Filtered By
TOPICS

198 results

Catheter-based left atrial appendage closure guided by intracardiac echocardiography in a patient with recurrent esophageal variceal bleedings

06 Jul 2026

A 76-year-old patient with permanent atrial fibrillation and recurrent oesophageal variceal bleeding can no longer receive oral anticoagulation, leaving stroke prevention as a major challenge. How would you manage this complex balance between thromboembolic and bleeding risk?

Frequency of the problem:
Expert level:

Author

Ole De Backer
Catheter-based left atrial appendage closure guided by intracardiac echocardiography in a patient with recurrent esophageal variceal bleedings

An unconventional pathway to the management of an iatrogenic dissection

23 Jun 2026

Iatrogenic coronary dissection is a rare but potentially life-threatening complication of PCI. Its management can be challenging, particularly when antegrade wiring fails and flow is compromised, requiring escalation to advanced bailout strategies.

Pablo Salinas

Author

Pablo Salinas
An unconventional pathway to the management of an iatrogenic dissection

All you need to know - Intracoronary imaging for vulnerable plaque

22 May 2026 – From EuroPCR 2026

This session provides a comprehensive overview of vulnerable plaque pathophysiology and the role of intracoronary imaging in its identification. It assesses treatment options, including the potential role of preventative PCI and intensive medical therapy, to guide clinical decision-making in managing plaque vulnerability.

All you need to know - Intracoronary imaging for vulnerable plaque

DCB: what we know and what we do not know

22 May 2026 – From EuroPCR 2026

This session provides a detailed update on drug-coated balloons (DCB) in interventional cardiology, covering the latest clinical data and trials. It identifies scenarios where DCB use is most effective and offers guidance on optimizing procedural techniques to enhance clinical outcomes.

DCB: what we know and what we do not know

Multivessel disease or left main disease

22 May 2026 – From EuroPCR 2026

This session explores revascularisation strategies for patients with multivessel or left main coronary artery disease. It emphasizes the role of intravascular physiology and imaging in guiding treatment decisions and highlights procedural factors that contribute to improved long-term clinical outcomes, supported by complex case discussions.

Spontaneous coronary artery dissection management with intracoronary imaging

22 May 2026 – From EuroPCR 2026

Explore the nuanced management of spontaneous coronary artery dissection (SCAD) with a focus on intracoronary imaging. This session examines diagnostic challenges, the limited role of coronary CT angiography, and strategies for managing occlusive SCAD cases, highlighting the evolving understanding of this complex condition.

Insight from recent evidence in coronary artery disease: value of DCB for de novo lesions (SELUTION) and imaging for left main PCI (OPTIMAL)

21 May 2026 – From EuroPCR 2026

This session reviews pivotal recent evidence impacting daily practice in coronary artery disease management. It discusses the role of drug-coated balloons (DCB) for de novo lesions as evaluated in the SELUTION trial and evaluates intracoronary imaging strategies for left main PCI as presented in the OPTIMAL...

Insight from recent evidence in coronary artery disease: value of DCB for de novo lesions (SELUTION) and imaging for left main PCI (OPTIMAL)

DCB as a key player in the management of complex coronary lesions

21 May 2026 – From EuroPCR 2026

This session highlights the pivotal role of drug-coated balloons (DCB) in managing complex coronary lesions. Experienced operators share their approaches to applying DCB in challenging clinical and anatomical settings, optimized by intravascular imaging guidance. The discussion includes insights from the LatamBif Registry and other series on...

New insights in coronary atherosclerosis using intracoronary imaging

21 May 2026 – From EuroPCR 2026

This session provides new insights into coronary atherosclerosis through intracoronary imaging studies. It investigates the relationship between Lp(a) levels and high-risk plaques, characteristics of vulnerable plaques and thrombus in ACS, non-culprit lesion events, lipid core burden in STEMI, and the prognostic value of AI-derived lipid-to-cap ratios,...

Imaging-guided CTO PCI

21 May 2026 – From EuroPCR 2026

This session focuses on imaging-guided CTO PCI, presenting cases that illustrate the utility of OCT, CT, and IVUS for lesion assessment and procedural guidance. Topics include woven-like CTOs, double CTO evaluation, management of late stent malapposition, and strategies for navigating complex occlusions to optimize outcomes.